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We have developed a PCR– high-resolution melt (PCR-HRM) assay to discriminate nontypeable Haemophilus influenzae
(NTHi) colonies from Haemophilus haemolyticus. This method is rapid and robust, with 96% sensitivity and 92% specificity
compared to the hpd#3 assay. PCR-HRM is ideal for high-throughput screening for NTHi surveillance and clinical trials.
Nontypeable Haemophilus influenzae (NTHi) is an importantcause of respiratory system-related infections, including oti-
tis media (OM), exacerbations of chronic obstructive pulmonary
disease, chronic bronchitis, and bronchiectasis (1–3). There are
also reports of its increasing importance as a cause of invasive
infections in regions with H. influenzae type b immunization (4–
6). NTHi isolates have colony phenotypes similar to those of non-
hemolytic Haemophilus haemolyticus (7), a respiratory tract com-
mensal that rarely causes disease (8, 9). Therefore, correct
identification of NTHi requires novel methods of discrimination
to complement traditional culture techniques (10, 11).
Clinical trials are under way to assess the effect of antibiotics
and the 10-valent pneumococcal H. influenzae protein D-
conjugate vaccine (PHiD-CV; Synflorix) on NTHi nasopharyn-
geal carriage and infection (for example, NCT01735084 and
NCT01174849). An 11-valent precursor to PHiD-CV reduced
NTHi-associated acute otitis media by 35% (12). Although a re-
duction in H. influenzae nasopharyngeal carriage was observed
following primary and booster vaccination with the 11-valent vac-
cine (17), no substantial effect has been observed on NTHi car-
riage in subsequent studies with PHiD-CV, which has 8 of 10
serotypes conjugated to protein D (20, 21). Whether or not
PHiD-CV will afford protection against OM or other NTHi infec-
tions, particularly in high-risk populations, is yet to be deter-
mined.
Given the high rates of misidentification of NTHi as the closely
related commensal H. haemolyticus by standard culture-based
techniques (10, 16), accurate molecular identification of NTHi is
essential for surveillance of NTHi-targeted therapies. The devel-
opment of a molecular tool for NTHi identification that can also
identify H. haemolyticus will enable a greater understanding of the
role of H. haemolyticus in carriage and disease. In addition, H.
haemolyticus also expresses protein D (17), the NTHi antigen used
in PHiD-CV. An assay that permits detection of H. haemolyticus is
therefore important to monitor the impact of PHiD-CV on H.
haemolyticus colonization. We have previously shown that the
hpd#3 probe-based real-time PCR (RT-PCR) (13) provided supe-
rior NTHi identification compared to other PCR assays (14). We
have utilized the discriminatory power of the hpd gene to develop
a rapid PCR– high-resolution melt (PCR-HRM) assay for high-
throughput identification of NTHi and discrimination from H.
haemolyticus.
Two reference strains (H. haemolyticus ATCC 33390 and NTHi
86-028NP [15]), 60 nasopharyngeal carriage isolates from West-
ern Australian children with and without a history of recurrent
acute OM (14, 16) (20 NTHi, 19 H. haemolyticus, and 21 ambig-
uous Haemophilus isolates by 16S rRNA gene PCR), and 151 iso-
lates from Northern Territory children with bronchiectasis (3) (49
nasopharyngeal, 52 bronchoalveolar lavage, and 50 throat isolates
identified as NTHi or not by hpd#3 RT-PCR) were used to develop
and validate the PCR-HRM assay. The Western Australian isolates
were specifically chosen to represent NTHi, H. haemolyticus, and
ambiguous strains, while the Northern Territory isolates were a
sequential selection of clinical isolates selected to validate the
method. Isolates were identified by colonial morphology, X and V
growth factor dependence, and lack of reaction with capsular an-
tisera using the Phadebact Haemophilus coagglutination test, and
genomic DNA (gDNA) was isolated as previously described (16).
gDNA was eluted in 100 l sterile water and either used immedi-
ately or stored in aliquots at20°C.
We assessed published DNA sequences for the gene encoding
protein D, hpd, from NTHi and H. haemolyticus (13) and identi-
fied a hypervariable region (bp 580 to 1010) with potential dis-
criminatory power. This region was amplified from the gDNA of
31 diverse strains using primers hpd1 fwd (5=-CAAAGTGTTGAA
AAAATATGGCTATGA-3=) and hpd1 rev (5=-GTTGCACCTGA
TTTATTCAATAATGC-3=). Amplicons were then sequenced by
the Australian Genome Research Facility using primers hpd2 fwd
(5=-TTGCCTGGTTTAGATTGTTC-3=) and hpd2 rev (5=-GTTC
AATTAGTGGCTTATACGG-3=) and standard DNA sequencing
techniques (18). The hpd1 amplification primers were used for
sequencing in cases where hpd2 sequencing reactions failed.
Alignment of our and all published hpd sequences identified
polymorphic regions suitable for differentiating NTHi from H.
haemolyticus. PCR primers were designed to amplify a 50-bp
product containing two nucleotide polymorphisms for differen-
tiation of NTHi (A and T) from H. haemolyticus (G and G) using
high-resolution melt (HRM) technology (Table 1). Degeneracies
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in the reverse primer were necessary to ensure hpd amplification
in both NTHi and H. haemolyticus. The BLAST function (NCBI)
was used to rule out primer sequence similarity with other species
of respiratory bacteria.
Real time-PCR and the HRM assay were performed on the
Rotorgene 6000 system (Corbett Life Science). Reaction mixtures
contained 5 l of 2 SensiMix SYBR green (Bioline), 100 nM
(each) primer, and 1 l of gDNA in a total volume of 10 l. To
reduce sample preparation time, the PCR-HRM method was also
tested using 1 l of a colony boil preparation rather than gDNA.
Two to three Haemophilus colonies from a subset of isolates were
placed into 200l sterile water, heated at 100°C for 10 min, placed
on ice, and centrifuged, and 1 l of supernatant was used in the
PCR-HRM assay. Cycling conditions were 50°C for 2 min, 95°C
for 2 min, and then 40 cycles of 95°C for 15 s, 66°C for 15 s, and
70°C for 30 s. The HRM assay was carried out from 65°C to 80°C
in 0.1°C increments for 2 s each. Raw HRM curves were normal-
ized in the region of 64.5 to 79°C prior to analysis using the Ro-
torgene 6000 software v1.7. All samples were run in duplicate and
were required to be within 0.5 cycles.
Based on all available sequences for the 50-bp amplicon of the
hpd gene and the assumption that GC content defines the melting
temperature (19), 6 different melt curves were predicted (Table 1,
curves A to F). The PCR-HRM assay was conducted on all 31
TABLE 1 Variant NTHi and H. haemolyticus sequences amplified by hpd HRM primers
Identifier Species 50-bp sequence (5= to 3=) % GC Curve
Hi86 NTHi ATGGATTTGAAATTAGTTCAATTAATTGCTTATACAGATTGGAAAGAAAC 26 A
H17 NTHi ATGGATTTGAAATTAGTTCAATTAATTGCTTATACAGACTGGAAAGAAAC 28 B
H4 H. haemolyticus ATGGATTTGAAATTAGTTCAATTAGTGGCTTATACAGATTGGAAAGAAAC 30 C
33390 H. haemolyticus ATGGATTTGAAATTAGTTCAATTAGTGGCTTATACGGATTGGAAAGAAAC 32 D
H9 H. haemolyticus ATGGATTTGAAATTAGTTCAATTAGTGGCTTATACTGACTGGCAAGAAAC 34 E
H12 H. haemolyticus ATGGATTTGAAACTAGTTCAATTAGTGGCTTATACGGATTGGAAAGAAAC 34 E
H47 H. haemolyticus ATGGATTTGAAATTAGTTCAATTAGTGGCTTATACTGACTGGCATGAAAC 34 E
H16 H. haemolyticus ATGGATTTGAAACTAGTTCAATTAGTGGCTTATACTGACTGGCATGAAAC 36 F
Forward primer hpd HRM FWD ATGGATTTGAAATTAGTTCAATTA
Reverse primer hpd HRM REV CGAATATGHCTRACCKTWCTTTG
FIG 1 Normalized PCR-HRM curves of NTHi and H. haemolyticus variants. NTHi amplicons encompass an internal ATT and melt earlier (blue) than do H.
haemolyticus amplicons, which encompass an internal GTG (red). A to F relate to curve types in Table 1.
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sequenced isolates, and curves representing each of the 6 unique
sequence types are shown in Fig. 1. The largest temperature de-
marcation occurred between NTHi and H. haemolyticus isolates,
as would be predicted by the central A-to-G and T-to-G single
nucleotide polymorphisms (SNPs). The PCR-HRM assay was
then conducted on gDNA of the remaining 180 isolates (29 West-
ern Australian and 151 Northern Territory isolates). Figure 2
shows the melt curves from 19 representative isolates tested (in-
cluding the 2 reference strains). One hundred sixty-one of the 180
isolates clustered with the melt curves for either NTHi or H. hae-
molyticus reference strains. Isolates were classified as NTHi or H.
haemolyticus based on the reference strain with which they clus-
tered. Compared with the hpd#3 RT-PCR assay, the PCR-HRM
assay had 96% sensitivity and 92% specificity (Table 2). This was
based on the assumption that for microbiologically identified
Haemophilus isolates, a positive hpd#3 RT-PCR assay confirmed
H. influenzae and that an hpd#3 RT-PCR-negative result identified
presumptive H. haemolyticus. The PCR-HRM assay also allowed
the clear classification of strains that were previously ambiguous
by 16S rRNA gene PCR. A comparison of the PCR-HRM assay on
gDNA versus colony boils demonstrated that both DNA prepara-
tion methods worked equally well; the colony boil method is now
standard for our studies.
Nineteen Haemophilus isolates (4 ambiguous Western Austra-
lian and 15 Northern Territory isolates that were all X and V factor
dependent) could not be amplified and were also negative by the
hpd#3 RT-PCR assay. The failure to amplify suggests significant
variation or absence of the hpd gene. While this is a limitation of
the current assay, the 4 ambiguous Western Australian isolates
could not be classified using other PCR targets (ompP2, ompP6,
lgtC, 16S rRNA, fucK, and iga [11]) and are a reminder that com-
plete species differentiation by PCR will likely remain elusive.
Design of a conserved reverse primer downstream from the
chosen discriminatory SNPs was not possible for amplification of
both Haemophilus species. Therefore, a degenerate primer which
could add complexity to the amplicon melt profile was designed;
that is, amplicon variation may widen the area at which species-
specific curves fall, potentially obscuring species differentiation.
To gauge this potential effect, we conducted the PCR-HRM assay
on representatives of each amplicon variant identified from the
FIG 2 Separation of PCR-HRM curves from 8 H. haemolyticus (black) and 9 NTHi (green) isolates. All H. haemolyticus isolates align with the reference H.
haemolyticus strain ATCC 33390, shown in red, and NTHi isolates align with NTHi reference strain 86-028NP, shown in blue. Duplicate reactions are displayed.
TABLE 2 Comparison of sensitivity and specificity for molecular
detection of suspected H. influenzae coloniesa
Assay for H.
influenzae
detection
TP/TP
TN
%
sensitivity 95% CI
TN/TN
FP
%
specificity 95% CI
hpd#3 assay 134/138 97.1 92–99 48/54 88.8 77–95
hpd HRM assay 134/140 95.7 90–98 48/52 92.3 81–97
a Abbreviations: TP, number of true positives; TN, number of true negatives; FP,
number of false positives; CI, confidence interval.
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sequencing. There was 1°C separation between the highest melt
curve for the NTHi variants (74.6°C) and the lowest melt curve for
H. haemolyticus variants (75.6°C). Furthermore, as shown in Fig. 1
and 2, the dichotomous separation of isolates by HRM was almost
completely explained by the GC differences of the internal SNPs
with seemingly little influence by GC variation in the primer re-
gion. In short, variation in the primer region had little effect on the
melting temperature and no effect on assay outcome. This may be
the result of a primer binding bias within the degenerate primer
pool despite the stringency of the relatively high annealing tem-
perature used for this assay. Furthermore, despite the potential for
overlap in GC content theoretically afforded by the degenerate
primer, this has not been observed.
NTHi has a significant role in morbidity, and thus, accurate
surveillance is required for determining vaccine efficacy (i.e., the
impact of Synflorix) and monitoring antibiotic resistance. The
hpd#3 RT-PCR assay (13) is useful for discriminating H. influen-
zae from closely related Haemophilus species and can be applied to
swabs directly. However, in the context of routine microbiological
identification of NTHi, the PCR-HRM assay is rapid (colony boil
preparations), accurate, and inexpensive (no probe required) and
has potential for high-throughput analysis. It also has the added
advantage of identifying H. haemolyticus. In summary, our PCR-
HRM assay allows discrimination of NTHi from H. haemolyticus
and has excellent concordance with the hpd#3 RT-PCR assay.
Nucleotide sequence accession numbers. The hpd sequences
were deposited in GenBank under accession numbers KF048057
to KF048087.
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